Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 21, Issue 5, Pages 457-466
Publisher
Springer Nature
Online
2015-04-08
DOI
10.1038/nm.3839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem-like Cell Traits in Breast Cancer
- (2014) M.-L. Luo et al. CANCER RESEARCH
- Prolyl isomerase Pin1 in cancer
- (2014) Zhimin Lu et al. CELL RESEARCH
- Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
- (2013) Jonathan D. Moore et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
- (2013) E. M. Rego et al. BLOOD
- Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
- (2013) R. M. Connolly et al. CLINICAL CANCER RESEARCH
- Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data
- (2013) Preetesh Jain et al. Clinical Lymphoma Myeloma & Leukemia
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
- (2013) Julien Ablain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis
- (2013) Qi Li et al. PLoS One
- Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
- (2013) G Gausdal et al. Cell Death & Disease
- Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
- (2012) Kazuhiro Nakamura et al. CELL
- Negative Regulation of the Stability and Tumor Suppressor Function of Fbw7 by the Pin1 Prolyl Isomerase
- (2012) Sang-Hyun Min et al. MOLECULAR CELL
- ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
- (2012) Weiwei Yang et al. NATURE CELL BIOLOGY
- Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
- (2011) D. V. Urusova et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Modern Approaches to Treating Acute Promyelocytic Leukemia
- (2011) Miguel A. Sanz et al. JOURNAL OF CLINICAL ONCOLOGY
- (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo
- (2011) G A S dos Santos et al. LEUKEMIA
- Regulation of Estrogen Receptor N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1
- (2011) P. Rajbhandari et al. MOLECULAR AND CELLULAR BIOLOGY
- Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular Function
- (2011) Tae Ho Lee et al. MOLECULAR CELL
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Oscar Arrieta et al. JOURNAL OF CLINICAL ONCOLOGY
- Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1
- (2010) N. Sheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR and PML-RAR
- (2009) M. Gianni' et al. CANCER RESEARCH
- Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins
- (2009) Ayako Nakano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
- (2009) Andrea Decensi et al. JOURNAL OF CLINICAL ONCOLOGY
- Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation
- (2009) Y Liao et al. ONCOGENE
- Effects of All-Trans Retinoic Acid on Th1- and Th2-Related Chemokines Production in Monocytes
- (2008) Yu-Chien Tsai et al. INFLAMMATION
- Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
- (2008) Kristopher J. Stanya et al. JOURNAL OF CELL BIOLOGY
- Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT I
- (2008) Rodryg Ramlau et al. JOURNAL OF CLINICAL ONCOLOGY
- Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability
- (2008) Prudence B Lam et al. Molecular Cancer
- The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network
- (2008) Min Sup Song et al. NATURE
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started